Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.5K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

163
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
163
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

532
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
532
Improving Translational Accuracy02:07

Improving Translational Accuracy

12.2K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
12.2K
Improving Translational Accuracy02:07

Improving Translational Accuracy

3.3K
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune Architecture.

Cancer discovery·2026
Same author

Turep: Detecting cross-cancer tumor-reactive T cells in single-cell and spatial transcriptomics data.

bioRxiv : the preprint server for biology·2026
Same author

The dynamic landscape of alternative splicing during silicosis progression.

Respiratory research·2026
Same author

Serial Thermal Ablation Induces Abscopal Antitumor Immunity and Reveals Targetable CSF1R-Dependent Resistance in Pancreatic Cancer.

bioRxiv : the preprint server for biology·2026
Same author

BDCD: a comprehensive Brain Disease Cell-cell communication Database.

Database : the journal of biological databases and curation·2026
Same author

A Robust ConvNeXt-Based Framework for Efficient, Generalizable, and Explainable Brain Tumor Classification on MRI.

Bioengineering (Basel, Switzerland)·2026

Related Experiment Video

Updated: Nov 12, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.9K

Deep generative neural network for accurate drug response imputation.

Peilin Jia1, Ruifeng Hu2, Guangsheng Pei2

  • 1Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA. peilin.jia@uth.tmc.edu.

Nature Communications
|March 20, 2021
PubMed
Summary

This study introduces a deep learning model to predict cancer drug response by analyzing gene expression. The method accurately imputes treatment outcomes, outperforming existing approaches and aiding in identifying key response markers.

More Related Videos

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

750
Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline
10:44

Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline

Published on: December 7, 2021

2.4K

Related Experiment Videos

Last Updated: Nov 12, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.9K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

750
Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline
10:44

Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline

Published on: December 7, 2021

2.4K

Area of Science:

  • Computational biology
  • Genomics
  • Cancer research

Background:

  • Cancer drug response varies significantly due to tumor heterogeneity.
  • Tumor microenvironment and transcriptome context critically influence treatment outcomes.

Purpose of the Study:

  • To develop a deep variational autoencoder (VAE) model for compressing gene expression data.
  • To accurately impute cancer drug response using low-dimensional latent vectors.
  • To identify signatures and markers associated with drug response.

Main Methods:

  • Developed a deep variational autoencoder (VAE) model to encode gene expression into latent vectors.
  • Validated the model's accuracy using cell line lineage, cross-validation, and independent clinical datasets.
  • Applied the model to The Cancer Genome Atlas (TCGA) data for further analysis.

Main Results:

  • The VAE model accurately imputes drug response, outperforming standard gene signature methods.
  • The expression-regulated component (EReX) of drug response showed high cross-panel correlation.
  • Identified associations between imputed drug response and factors like tumor microenvironment and mutation burden.

Conclusions:

  • Deep learning offers a powerful approach for imputing and understanding cancer drug response.
  • The developed method effectively handles tumor heterogeneity and identifies key response predictors.
  • This work provides valuable insights for personalized cancer therapy and biomarker discovery.